Replies to post #741315 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

It wasn’t an easy task, but I concluded that there were probably 3 or 4.

Here is medicine number 4, approved by MHRA on 31 December 2024.

Tarlatamab approved to treat adult patients with small cell lung cancer.

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 31 December 2024, approved the medicine tarlatamab (Imdyllytra) to treat adult patients with small cell lung cancer (SCLC) that has spread throughout the lungs and/or to other parts of the body.

https://www.gov.uk/government/news/tarlatamab-approved-to-treat-adult-patients-with-small-cell-lung-cancer

This medicine had its first CHM meeting on 2/22/24.

a medicine used to treat adult patients with small cell lung cancer that has spread
throughout the lungs and/or to other parts of the body and where treatment with
chemotherapy that contains platinum did not work or is no longer working.

https://app.box.com/s/jv487awvqzzsrdql0o34h9gg350ceyd4/file/1722451876042